Ultragenyx Pharmaceutical
RARE
RARE
161 hedge funds and large institutions have $2.35B invested in Ultragenyx Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 53 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
41% less capital invested
Capital invested by funds: $3.98B → $2.35B (-$1.63B)
Holders
161
Holding in Top 10
2
Calls
$9.27M
Puts
$10.5M
Top Buyers
| 1 | +$116M | |
| 2 | +$19.1M | |
| 3 | +$18.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.5M |
| 5 |
O
OrbiMed
New York
|
+$8.12M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$13.8M | |
| 3 | -$12.5M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$12.5M |
| 5 |
Jennison Associates
New York
|
-$10.8M |